Trial · NCT02094352
Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome
NCT02094352, Phase 2, Terminated, Hospital for Special Surgery, New York; results first posted 2017-06-14
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome. Trials, record NCT02094352. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02094352
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Randomized Controlled Trial of Ketamine Infusion With Continuous Epidural Infusion for Treatment of Complex Regional Pain Syndrome
- NCT number
- NCT02094352
- Status
- Terminated
- Phases
- Phase 2
- Enrollment
- 3 participants, actual
- Lead sponsor
- Hospital for Special Surgery, New York
- Conditions
- Complex Regional Pain Syndrome
- Interventions
- Ketamine Infusion + Epidural Infusion, Control Group + Epidural infusion, Ketamine Booster Infusion, Control Group Booster Infusion
- First posted
- 2014-03-21
- Last updated
- 2018-01-31
- Results first posted
- 2017-06-14
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Pain Reduction | 6 months post infusion | Evidence of changes in NRS pain scores between baseline and six months post infusion |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Pain Reduction | 6 months post infusion | Study terminated early due to lack of enrollment. We did not analyze any data. |
Source ClinicalTrials.gov
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Ketamine Infusion + Epidural Infusion + Booster Infusion | 2 | |
| Overall Study | STARTED | Control Group + Epidural Infusion + Booster Infusion | 1 | |
| Overall Study | COMPLETED | Ketamine Infusion + Epidural Infusion + Booster Infusion | 2 | |
| Overall Study | COMPLETED | Control Group + Epidural Infusion + Booster Infusion | 1 | |
| Overall Study | NOT COMPLETED | Ketamine Infusion + Epidural Infusion + Booster Infusion | 0 | |
| Overall Study | NOT COMPLETED | Control Group + Epidural Infusion + Booster Infusion | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Ketamine Infusion + Epidural Infusion + Booster Infusion | ||
| Total, all-cause mortality | Control Group + Epidural Infusion + Booster Infusion | ||
| Total, other adverse events | Ketamine Infusion + Epidural Infusion + Booster Infusion | 0 | 2 |
| Total, other adverse events | Control Group + Epidural Infusion + Booster Infusion | 0 | 1 |
| Total, serious adverse events | Ketamine Infusion + Epidural Infusion + Booster Infusion | 0 | 2 |
| Total, serious adverse events | Control Group + Epidural Infusion + Booster Infusion | 0 | 1 |
Source ClinicalTrials.gov
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Ketamine Infusion + Epidural Infusion + Booster Infusion vs Control Group + Epidural Infusion + Booster Infusion: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02094352
GET https://conductscience.org/api/trials/v1/NCT02094352/registered